Product Details
| Product Name: LL-37 | CAS No.: 597562-32-8 |
| EC-No.: 200-001-8 | Min. Order: 1kit |
| Purity: 99% | Supply Ability: 1000 kits |
| Release date: 2026/06/08 | |
| Inventory: >100 kits |
LL-37 is the C-terminal cleavage product of the cathelicidin peptide Hcap-18, which can directly kill bacteria, fungi and viruses. LL-37 also plays an immunomodulatory role by chemotactic immune cells, regulating the secretion of inflammatory promoters/inhibitors, and coordinating innate immunity and acquired immunity. LL-37 can also act on vascular endothelial cells and epithelial cells to stimulate angiogenesis and promote injury repair.
Product Name | LL-37 |
CAS | 597562-32-8 |
Appearance | White powder |
MF | C205H341N61O52 |
Molecular Weight | 4492.27854 |
Purity | 99% |
Storage | Keep in a cool, dry, dark location in a tightly sealed container or cylinder |
Shelf Life | 24 Months |
Purchase process:
1. Contact the sales department to confirm the product name, quantity, price, packaging, etc.
2. After confirmation, remit the money to our company account and send detailed delivery information
3. Ship within 2 working days after payment and offer tracking number.
4. Customer confirms receipt
Rock
Whatsapp:+8618829283179
Email: rock@horlden.com
LL-37
Company Profile Introduction
You may like
-
CAS:1150-90-9
-
CAS:129954-34-3
-
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-06-09 | ||
| $9.00 |
VIP1Y
|
Guangzhou XinPeptide International Co.,Ltd
|
2026-06-09 | |
|
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2026-06-08 | ||
|
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | ||
| $1870.00 |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
| $70.00 |
VIP3Y
|
Zibo Hangyu Biotechnology Development Co., Ltd
|
2026-05-05 | |
| $800.00 |
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2026-02-02 | |
| $1.00 |
VIP1Y
|
Hainan Fubai Trading Co., LTD
|
2026-01-14 | |
|
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2025-12-24 | ||
| $838.78 |
VIP1Y
|
TsurgeX Pharmaceutical Technology Co., Ltd.
|
2025-11-27 |
China